Work

Development of a neuromedin U–human serum albumin conjugate as a long‐acting candidate for the treatment of obesity and diabetes. Comparison with the PEGylated peptide

Year: 2013

Type: article

Source: Journal of Peptide Science

DOI: 10.1002/psc.2582

Authors: Philippe Neuner, Andrea M. Peier, Fabio Talamo, Paolo Ingallinella, Armin Lahm, Gaetano Barbato, Annalise Di Marco, Kunal Desai, Karolina Zytko, Ying Qian, Xiaobing Du, Davide Ricci, Edith Monteagudo, Ralph Laufer, Alessandro Pocai, Elisabetta Bianchi, Donald J. Marsh, Antonello Pessi

Institutions: Novartis (Switzerland), IRBM, Novartis Institutes for BioMedical Research, Merck & Co., Inc., Rahway, NJ, USA (United States), University of Rome Tor Vergata, CEINGE Biotecnologie Avanzate Franco Salvatore (Italy)

Language: English

Topic: Chemical Synthesis and Analysis

Subfield: Organic Chemistry

Field: Chemistry

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1958248331

FWCI: 1.529

Cites: 58

Cited by: 31

Related to: 10